Logo image of CLST

CATALYST BANCORP INC (CLST) Stock Fundamental Analysis

NASDAQ:CLST - Nasdaq - US14888L1017 - Common Stock - Currency: USD

11.68  +0.02 (+0.17%)

Fundamental Rating

1

Overall CLST gets a fundamental rating of 1 out of 10. We evaluated CLST against 402 industry peers in the Banks industry. Both the profitability and financial health of CLST have multiple concerns. CLST is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CLST had negative earnings in the past year.
CLST had a positive operating cash flow in the past year.
In multiple years CLST reported negative net income over the last 5 years.
CLST had a positive operating cash flow in 4 of the past 5 years.
CLST Yearly Net Income VS EBIT VS OCF VS FCFCLST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.21%, CLST is doing worse than 97.28% of the companies in the same industry.
Looking at the Return On Equity, with a value of -4.16%, CLST is doing worse than 95.05% of the companies in the same industry.
Industry RankSector Rank
ROA -1.21%
ROE -4.16%
ROIC N/A
ROA(3y)-0.28%
ROA(5y)-0.09%
ROE(3y)-0.98%
ROE(5y)-0.47%
ROIC(3y)N/A
ROIC(5y)N/A
CLST Yearly ROA, ROE, ROICCLST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 2 -2

1.3 Margins

CLST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLST Yearly Profit, Operating, Gross MarginsCLST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 -40

2

2. Health

2.1 Basic Checks

CLST does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CLST has been reduced compared to 1 year ago.
The number of shares outstanding for CLST has been reduced compared to 5 years ago.
There is no outstanding debt for CLST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLST Yearly Shares OutstandingCLST Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
CLST Yearly Total Debt VS Total AssetsCLST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

The Debt to FCF ratio of CLST is 6.50, which is on the high side as it means it would take CLST, 6.50 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.50, CLST is doing worse than 70.05% of the companies in the same industry.
A Debt/Equity ratio of 0.24 indicates that CLST is not too dependend on debt financing.
CLST has a Debt to Equity ratio (0.24) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 6.5
Altman-Z N/A
ROIC/WACCN/A
WACC8.89%
CLST Yearly LT Debt VS Equity VS FCFCLST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CLST Yearly Current Assets VS Current LiabilitesCLST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2M 4M 6M 8M

0

3. Growth

3.1 Past

The earnings per share for CLST have decreased strongly by -625.79% in the last year.
CLST shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -39.26%.
CLST shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.56% yearly.
EPS 1Y (TTM)-625.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.08%
Revenue 1Y (TTM)-39.26%
Revenue growth 3Y-15.72%
Revenue growth 5Y-6.56%
Sales Q2Q%6.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CLST Yearly Revenue VS EstimatesCLST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CLST Yearly EPS VS EstimatesCLST Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLST. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLST Price Earnings VS Forward Price EarningsCLST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLST indicates a slightly more expensive valuation: CLST is more expensive than 62.87% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.25
EV/EBITDA N/A
CLST Per share dataCLST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CLST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CATALYST BANCORP INC

NASDAQ:CLST (3/7/2025, 8:15:14 PM)

11.68

+0.02 (+0.17%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-25 2024-07-25/bmo
Earnings (Next)N/A N/A
Inst Owners27.34%
Inst Owner Change32.22%
Ins Owners5.11%
Ins Owner Change0%
Market Cap49.99M
Analysts0
Price TargetN/A
Short Float %0.16%
Short Ratio0.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.04
P/FCF 16.25
P/OCF 14.43
P/B 0.61
P/tB 0.61
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.72
FCFY6.16%
OCF(TTM)0.81
OCFY6.93%
SpS1.29
BVpS19.08
TBVpS19.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.21%
ROE -4.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 55.66%
ROA(3y)-0.28%
ROA(5y)-0.09%
ROE(3y)-0.98%
ROE(5y)-0.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 6.5
Debt/EBITDA N/A
Cap/Depr 94.62%
Cap/Sales 7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC8.89%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-625.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.08%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-39.26%
Revenue growth 3Y-15.72%
Revenue growth 5Y-6.56%
Sales Q2Q%6.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y136.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y135.65%
OCF growth 3YN/A
OCF growth 5YN/A